Company Overview and News

8
Currency war erupts, and could shake up markets

1h theage.com.au
So say some of the best and brightest in the $5.1 trillion ($6.9 trillion)-per-day foreign-exchange market. US President Donald Trump took to Twitter Friday to accuse China and the European Union of "manipulating their currencies and interest rates lower."
IFK DGLD GS.PRB GS.PRA CS GS UGLD GLSSP JBK DSLV IFX VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI CSGKF GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

8
Currency war erupts, and could shake up markets

1h smh.com.au
So say some of the best and brightest in the $5.1 trillion ($6.9 trillion)-per-day foreign-exchange market. US President Donald Trump took to Twitter Friday to accuse China and the European Union of "manipulating their currencies and interest rates lower."
IFK DGLD GS.PRB GS.PRA CS GS UGLD GLSSP JBK DSLV IFX VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI CSGKF GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

8
Currency War Erupts as Trump Blasts China, EU for ‘Manipulating’ - Bloomberg

5h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
IFK DGLD GS.PRB GS.PRA CS GS UGLD GLSSP JBK DSLV IFX VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI CSGKF GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

8
Goldman Sachs Puts a Grim Number on Solar Slump for This Year - Bloomberg

2018-07-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DGLD GS.PRB GS.PRA CS GS UGLD GLSSP JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI CSGKF GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

3
After emerging-market rout, Investec ready to start buying again

2018-07-17 theedgemarkets
SINGAPORE (July 17): Investec Asset Management, which oversees US$36 billion in emerging-market fixed income, is ready to get back into the market after reducing risks at the start of the year.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

5
Boeing rethinks aerospace rulebook as ‘797’ plans take shape

2018-07-15 malaymail
CHICAGO, July 15 — Boeing Co is seeking to rewrite the rules for creating commercial jets as it hones plans for a new midrange jet nicknamed the 797.
DSLV VIIX DGLD CSSLF VIIZ SPR UTX CS CSGKF UGLD BOE ZIV USLV TVIX BA XIV

5
The most expensive city in the world to eat in

2018-07-13 theage.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

5
The most expensive city in the world to eat in

2018-07-13 smh.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

9
Wall Street Competes With Unregulated Banks for the Riskiest Loans - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NMR MQBKY DB DGLD GS.PRB GS.PRA CS GS UGLD GLSSP 8604 NRSCF JEF MQG JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG MCQEF GSJ GS.PRJ GS.PRI CSGKF N33 GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

3
Asia’s newest millionaires swap basket-case economy for fine art

2018-07-12 bworldonline
IN THE PHILIPPINES, where a fifth of the country lives beneath the poverty line, locals have a new obsession: fine art.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

5
These Are the Most Expensive Cities in the World - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

3
Asia's Newest Millionaires Swap Basket-Case Economy for Fine Art - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

3
A Banker, an Intern and a Reckoning for Wall Street Bro Culture - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

3
A banker, an intern and a reckoning for Wall Street 'bro' culture

2018-07-11 theage.com.au
On Tuesday, after weeks of rumbling inside Credit Suisse, Paul Dexter, a senior banker, was let go over a complaint of inappropriate behavior involving an intern. Rumours swirled in M&A circles.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

3
A banker, an intern and a reckoning for Wall Street 'bro' culture

2018-07-11 smh.com.au
On Tuesday, after weeks of rumbling inside Credit Suisse, Paul Dexter, a senior banker, was let go over a complaint of inappropriate behavior involving an intern. Rumours swirled in M&A circles.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 22542D670